Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for male pattern baldness
ChiCTR2000030967Phase 4Recruiting
- Sponsor
- Xi'an Xincheng Boshimei Medical Aesthetic Clinic
- Start
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type A in androgenetic alopecia (AGA), sponsored by Xi'an Xincheng Boshimei Medical Aesthetic Clinic. Primary endpoint: Hair count in a fixed 2-cm area. Started Mar 2020; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ChiCTR2000030967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030967.